The state of the US biosimilar market isn't as healthy as it should be despite significant advances in the past decade, ...

The Trump administration on Tuesday said it will challenge a federal judge’s order that blocks its planned 15% rate limit on ...

FDA staff cuts could trigger user fee clawback mechanism, but experts including Patrick Frey and David Risinger say immediate ...

Novo Nordisk focused on a unique argument in federal appeals court on Tuesday in a case that will consider the extent to ...

Cartesian Therapeutics reports sustained benefits of Descartes-08 CAR-T therapy in generalized myasthenia gravis patients, ...

The Trump administration will hike payments to Medicare Advantage insurers by more than $25 billion next year, according to ...

A congressional commission is calling for at least a $15 billion federal investment in America’s biotechnology sector, ...

Executives of major pharmaceutical companies warned the European Union that they’re likely to take the US’ side amid the threat of new tariffs.

A scrappy team of drug developers has come together to create new medicines for patients with autoimmune diseases and allergies. They're going after the bustling subfield of Graves' disease and ...

Multi-partnered ADC startup Duality Biologics is moving forward with its initial public offering plans on the Hong Kong Stock ...

Amy Com­stock Rick joined the FDA last No­vem­ber, and she not on­ly sur­vived the wide­spread staff cuts last week, she’s ...

Pharma tool and packaging production companies are readying themselves for direct impact from President Donald Trump’s ...